Skip to content
mapperlab
← Dashboard
Stock

EHC

Encompass Health Corporation
Health CareHealth Care FacilitiesLatest close $1067 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
7
27 funds tracked
Ever held
13
Current + past
New this quarter
0
Exited this quarter
1

Marquee-fund ownership over time

Nov 14, 2019May 17, 2021Nov 13, 2024May 15, 2026
Now
7

This quarter's activity

New positions opened

None.

Positions exited

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Bridgewater Associates$65$106+63%
Citadel Advisors$86$106+23%
AQR Capital Management$86$106+23%
Millennium Management$86$106+23%
Renaissance Technologies$102$106+4%
Two Sigma Investments$100$106+6%
D.E. Shaw$100$106+6%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
Point72 Asset Management 2× in & out→ $107-6%
Glenview Capital 2× in & out→ $109-3%
JANA Partners→ $60+8%
Maverick Capital 3× in & out→ $48-20%
Viking Global Investors→ $66+39%
Coatue Management→ $48-21%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at Encompass Health Corp. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
11
Filings · last 90d
49
Total on file
752
Recent SEC buffer
Most recent
May 18, 2026

30d / 90d windows measured from May 18, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 752 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · Encompass Health Corporation

Annual figures sourced directly from Encompass Health Corporation's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$5.94B
FY2025+10% YoY
Net income
$566.2M
FY2025+24% YoY
EPS (diluted)
$5.54
FY2025+24% YoY
Free cash flow(?)
$141M
FY2022-26% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for Encompass Health Corp — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Glenview CapitalQ4 2025Q1 2026$113$109-3%
Point72 Asset ManagementQ4 2025Q2 2026$113$107-6%
Two Sigma InvestmentsQ4 2024open$100$106+6%
D.E. ShawQ4 2024open$100$106+6%
Renaissance TechnologiesQ4 2024open$102$106+4%
Citadel AdvisorsQ3 2024open$86$106+23%
AQR Capital ManagementQ3 2024open$86$106+23%
Millennium ManagementQ3 2024open$86$106+23%
Point72 Asset ManagementQ3 2024Q1 2025$86$100+16%
Glenview CapitalQ4 2021Q1 2023$48$60+26%
Maverick CapitalQ3 2021Q4 2021$60$48-20%
Bridgewater AssociatesQ2 2021open$65$102+57%
JANA PartnersQ4 2020Q2 2023$55$60+8%
Maverick CapitalQ2 2020Q2 2021$48$66+35%
Viking Global InvestorsQ2 2020Q2 2021$47$66+39%
Coatue ManagementQ1 2020Q2 2020$61$48-21%
Maverick CapitalQ4 2019Q1 2020$51$61+20%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.